echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Soryuan Bio has been granted a new drug to treat Alzheimer's disease

    Soryuan Bio has been granted a new drug to treat Alzheimer's disease

    • Last Update: 2021-02-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    recently, precision medicine company Soyuan Bio announced that it has obtained authorization from Finland's Orion Corporation to treat ORM-12741, a new drug for Alzheimer's disease.the global rights to the development, manufacture and commercialization of ORM-12741.about ORM-12741 ORM-12741 is a selective, powerful, brand new antagonist with a target of α-2C epinephrine ligands (AR), which may be effective for psychotic disorders such as Alzheimer's disease, schizophrenia and depression., more than 540 patients in 11 clinical studies have taken ORM-12741, confirming the drug's safety and tolerance. A Phase IIa study of ORM-12741 was presented at the 65th Annual Meeting of the American Academy of Neurology (AAN).the study showed that patients who used ORM-12741 had a 4 percent improvement in memory scores over 12 weeks, while the placebo group had a 33 percent improvement. THE orM-12741 has a particularly beneficial effect on situational memory. (Drug Information Network)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.